Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Mounjaro a day early is unlikely to cause harm in a one-off situation, and the licensed schedule does allow a small timing window. Each weekly injection of tirzepatide maintains an active level in your body for several days, which means a 24-hour shift rarely creates a clinical problem. That said, these are prescription-only medicines, and any change to your injection schedule should be confirmed with your prescriber rather than decided alone. Here is what the clinical evidence and product guidance actually say.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching this question have a practical reason: a holiday, a work trip, a family commitment that falls on injection day. The assumption they often arrive with is one of two extremes — either that taking Mounjaro a day early is dangerous and forbidden, or that the timing is entirely flexible and it doesn't really matter. Both are oversimplifications.
The reality sits between them. Tirzepatide is a once-weekly subcutaneous injection, and "once weekly" is not a rigid 168-hour rule with zero tolerance. The product guidance, as described in the Mounjaro SmPC on the eMC, does allow a rescheduling window of roughly two days either side of your usual day, provided doses are not taken more frequently than once per week overall. A single day's shift (taking it on a Thursday instead of your usual Friday, for example) sits comfortably within that window for most people.
What the guidance does not permit is treating the injection as something you can take whenever you feel like it. The weekly interval exists for a reason: tirzepatide works by maintaining a sustained, consistent level in the body. Compress two injections too close together and you increase the risk of side effects, particularly nausea, vomiting and other gastrointestinal symptoms. The correction to the myth, then, is nuanced: occasional early administration within the permitted window is generally acceptable; habitual or significant compression of the interval is not. If you are thinking about whether your specific situation allows an early dose, that question is worth putting to your prescriber directly.
Understanding why a single day rarely matters requires a brief look at how the medicine behaves in the body. Tirzepatide has a plasma half-life of approximately five days. This means that even if you take your injection a full day early, the circulating level changes only slightly, the body is still processing the previous week's dose throughout that period. There is no sudden cliff-edge of medication absence the day before your scheduled injection.
This is a meaningful pharmacological fact, and it is why the rescheduling window exists in the licensed guidance at all. The NHS medicines page for tirzepatide confirms that Mounjaro is taken once a week but notes the flexibility available if the usual day is inconvenient, always with the caveat that you should not exceed one injection per week.
A day early is not the same as two days early. Many patients also find it helpful to read about whether it is ok to take Mounjaro a day early, which explores the clinical reasoning in more detail. If you are weighing up a larger shift, the pharmacological picture changes somewhat, and the considerations around taking Mounjaro two days early are worth reading separately. The key variable in both cases is the minimum gap between consecutive doses: your prescriber's advice, not a general rule found online, is the definitive answer for your situation.
Even within the permitted window, taking Mounjaro early is not automatically free of any consequence. The most common side effects (nausea, loose stools, reflux, fatigue) tend to be linked to dose changes or to the period shortly after injection, when tirzepatide levels are rising. If you take your injection a day early and already have residual GI sensitivity from the previous week's dose, that overlap can occasionally intensify symptoms.
This is worth knowing because some people interpret early-dose GI symptoms as a sign something has gone wrong, rather than as a normal feature of the medicine's action. Mild, short-lived nausea after an injection is common. Severe, persistent stomach pain that extends into the back is a different matter entirely; that warrants prompt medical attention, as the MHRA has highlighted in its safety guidance on GLP-1 medicines.
If you use oral contraceptives, there is an additional note worth flagging: tirzepatide can slow gastric emptying, which may reduce absorption of the pill. Your prescriber should have discussed adding a non-oral contraceptive method during dose changes, this applies to the usual weekly schedule, not just to early doses, but it is worth revisiting if your injection timing is shifting. Our frequently asked questions cover contraception considerations alongside other practical queries.
For anyone who has recently started treatment and has general questions about how the medicine works, our overview of tirzepatide covers the mechanism, the dose schedule and what to expect in the early weeks. Cost questions sometimes arise at the same time as scheduling ones, our Mounjaro cost page sets out the pricing context honestly.
If you need to take your injection one day early this week because of travel or a diary clash, and the gap from your last dose will still be at least six days, the guidance suggests this is generally acceptable. Make a note of the new day, check the Patient Information Leaflet, and treat that day as your new weekly injection day going forward if the change is permanent, or return to your original day the following week if it was a one-off. Do not take a second injection to "correct" back to the original schedule; just pick up on the usual day next time. For a fuller look at the practical steps involved, our page on whether you can do your Mounjaro jab a day early walks through the process clearly.
If you are regularly finding that your injection day doesn't work for you, that is worth raising at your next clinical review rather than improvising each week. Prescribers can often help you select a day that fits your actual life rather than the one you chose arbitrarily when you started.
The pen that arrives from our pharmacy in its plain, unbranded DPD box comes with a Patient Information Leaflet that covers exactly this, store it, refer to it, and contact your prescriber if you are unsure. Our clinical team, overseen by our lead prescriber, is available seven days a week for aftercare queries. If you haven't yet started treatment and want a clearer picture of your options, check your eligibility with a free consultation, a real clinician reviews it the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.